Cancer related cognitive impairment (CRCI) is commonly associated with cancer and its
treatments, yet the present binary diagnostic approach fails to capture the full spectrum of …

Introduction Identifying reliable biomarkers that reflect cancer survivorship symptoms
remains a challenge for researchers. DNA methylation (DNAm) measurements reflecting …

Doxorubicin (Dox), a widely used treatment for cancer, can result in chemotherapy‐induced
cognitive impairments (chemobrain). Chemobrain is associated with inflammation and …

Brain-derived neurotrophic factor (BDNF) improves cognitive function by stimulating
neurogenesis and neuroplasticity. We hypothesize that higher plasma BDNF levels are …

Many cancer patients experience serious cognitive problems related to their treatment,
which can greatly affect their quality of life. The molecular mechanisms of this cancer …

The frequently repeated administration of alprazolam (Alp), a highly effective
benzodiazepine sedative-hypnotic agent, in anxiety, insomnia, and other diseases is closely …

Cranial radiation therapy (RT) for brain cancers is often associated with the development of
radiation-induced cognitive dysfunction (RICD). RICD significantly impacts the quality of life …

Objective This research explored the combined effects of transcranial direct current
stimulation (tDCS) and aerobic exercise (AE) on executive function and specific serum …

Introduction: The anticancer drug doxorubicin (DOX) is used for various malignancies.
However, it also causes cognitive impairment in cancer survivors. In order to determine the …

Mood and anxiety disorders are complex psychiatric conditions shaped by the multifactorial
interplay of genetic, epigenetic, and neuropeptide factors. This review aims to elucidate the …